NO20083405L - Nye glycolipidadjuvantsammensetninger - Google Patents

Nye glycolipidadjuvantsammensetninger

Info

Publication number
NO20083405L
NO20083405L NO20083405A NO20083405A NO20083405L NO 20083405 L NO20083405 L NO 20083405L NO 20083405 A NO20083405 A NO 20083405A NO 20083405 A NO20083405 A NO 20083405A NO 20083405 L NO20083405 L NO 20083405L
Authority
NO
Norway
Prior art keywords
adjuvant compositions
glycolipid adjuvant
new glycolipid
new
compositions
Prior art date
Application number
NO20083405A
Other languages
English (en)
Other versions
NO341463B1 (no
Inventor
Ramasamy Mannar Mannan
Paul Joseph Dominowski
Sangita Mediratta
Original Assignee
Zoetis P Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis P Llc filed Critical Zoetis P Llc
Publication of NO20083405L publication Critical patent/NO20083405L/no
Publication of NO341463B1 publication Critical patent/NO341463B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18651—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse angår sammensetninger og fremgangsmåter for fremstilling av stabile adjuvansfortynnede forrådsløsninger og sluttadjuvansløsninger som innbefatter glykolipider, svake syrer, alkoholer, ikke-ioniske surfaktanter og buffere.
NO20083405A 2006-01-26 2008-08-04 Nye glykolipidaduvanssammensetninger NO341463B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76227906P 2006-01-26 2006-01-26
US81498406P 2006-06-20 2006-06-20
PCT/IB2007/000258 WO2007085962A2 (en) 2006-01-26 2007-01-15 Novel glycolipid adjuvant compositions

Publications (2)

Publication Number Publication Date
NO20083405L true NO20083405L (no) 2008-10-23
NO341463B1 NO341463B1 (no) 2017-11-20

Family

ID=38309580

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083405A NO341463B1 (no) 2006-01-26 2008-08-04 Nye glykolipidaduvanssammensetninger

Country Status (21)

Country Link
US (1) US8460679B2 (no)
EP (2) EP1991266B1 (no)
JP (1) JP5538725B2 (no)
KR (2) KR101202553B1 (no)
AR (1) AR059192A1 (no)
AU (1) AU2007209104B2 (no)
BR (1) BRPI0706709B8 (no)
CA (1) CA2634888C (no)
CY (1) CY1114310T1 (no)
DK (1) DK1991266T3 (no)
ES (1) ES2425576T3 (no)
HK (1) HK1128078A1 (no)
ME (3) ME01545B (no)
NO (1) NO341463B1 (no)
NZ (1) NZ569375A (no)
PL (1) PL1991266T3 (no)
PT (1) PT1991266E (no)
RS (2) RS52930B (no)
RU (1) RU2392965C2 (no)
TW (1) TWI372631B (no)
WO (1) WO2007085962A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0713978A2 (pt) * 2006-06-28 2012-11-27 Statens Seruminstitut expansão do repertório de células t para incluir epìtopos subdominantes através da vacinação com antìgeneos leberados como fragmentos de protéinas ou coquetéis de peptìdeo
JP5659332B2 (ja) * 2008-06-27 2015-01-28 ゾエティス・エルエルシー 新規なアジュバント組成物
AU2009298490A1 (en) 2008-10-03 2010-04-08 Cornell University Bovine herpes virus -1 compositions, vaccines and methods
CA2905162A1 (en) * 2013-03-15 2014-09-18 Glaxosmithkline Biologicals S.A. Composition containing buffered aminoalkyl glucosaminide phosphate derivatives and its use for enhancing an immune response
CA2924526A1 (en) 2013-09-19 2015-03-26 Paul Joseph Dominowski Water-in-oil emulsions comprising immunostimulatory oligonucleotides
CA2932878C (en) 2013-11-26 2020-11-03 Zoetis Services Llc Compositions for induction of immune response
LT3244920T (lt) 2015-01-16 2023-08-25 Zoetis Services Llc Snukio ir nagų ligos vakcina
CA2992892C (en) * 2015-07-20 2019-12-31 Zoetis Services Llc Liposomal adjuvant compositions
GB201703529D0 (en) 2017-03-06 2017-04-19 Cambridge Entpr Ltd Vaccine composition
CN110713520B (zh) * 2019-11-06 2021-01-01 中国石油天然气股份有限公司 油酰基氨基酸-γ-L-谷氨酰-L-半胱氨酰-甘氨酸多肽及其制备与应用
TW202206098A (zh) 2020-08-11 2022-02-16 美商碩騰服務公司 抗冠狀病毒疫苗
WO2022072431A1 (en) 2020-09-30 2022-04-07 Zoetis Services Llc Novel pasteurella multocida strains and vaccines having hyac and nanp deletions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291019A (en) * 1979-07-09 1981-09-22 Iowa State University Research Foundation, Inc. Vaccine for infectious bovine rhinotracheitis
DE3213650A1 (de) 1982-04-14 1983-10-27 Bayer Ag, 5090 Leverkusen N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr
DE3403495A1 (de) 1983-11-23 1985-05-30 Bayer Ag, 5090 Leverkusen Phosphorylierte glycosylamide, -harnstoffe, -carbamate und -thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung
DE3346623A1 (de) 1983-12-14 1985-07-04 Bayer Ag, 5090 Leverkusen N-glycosylierte harnstoffe, carbamate und thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung
DE3521994A1 (de) 1985-06-20 1987-01-02 Bayer Ag N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
NZ232740A (en) * 1989-04-20 1992-06-25 Riker Laboratories Inc Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
US6764682B1 (en) 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
US6290971B1 (en) * 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
FI109332B (fi) * 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
IL155073A0 (en) 2000-10-02 2003-10-31 Glaxosmithkline Biolog Sa Split enveloped virus preparation

Also Published As

Publication number Publication date
RS20080318A (en) 2009-05-06
RU2008129203A (ru) 2010-03-10
KR20080080223A (ko) 2008-09-02
NO341463B1 (no) 2017-11-20
PT1991266E (pt) 2013-08-28
NZ569375A (en) 2010-05-28
MEP4508A (en) 2010-06-10
EP1991266A2 (en) 2008-11-19
KR20110140140A (ko) 2011-12-30
BRPI0706709B8 (pt) 2021-05-25
DK1991266T3 (da) 2013-08-26
CA2634888C (en) 2016-06-21
KR101202553B1 (ko) 2012-11-20
EP1991266B1 (en) 2013-06-26
ME00045B (me) 2010-10-10
ES2425576T3 (es) 2013-10-16
AU2007209104B2 (en) 2010-04-08
AR059192A1 (es) 2008-03-12
RS52930B (en) 2014-02-28
WO2007085962A2 (en) 2007-08-02
RU2392965C2 (ru) 2010-06-27
AU2007209104A1 (en) 2007-08-02
HK1128078A1 (en) 2009-10-16
BRPI0706709A2 (pt) 2011-04-05
ME01545B (me) 2014-04-20
BRPI0706709B1 (pt) 2021-03-23
JP2009524638A (ja) 2009-07-02
CY1114310T1 (el) 2016-08-31
TWI372631B (en) 2012-09-21
PL1991266T3 (pl) 2013-11-29
CA2634888A1 (en) 2007-08-02
US20070196384A1 (en) 2007-08-23
TW200738268A (en) 2007-10-16
EP2481423A1 (en) 2012-08-01
WO2007085962A3 (en) 2007-12-27
US8460679B2 (en) 2013-06-11
JP5538725B2 (ja) 2014-07-02

Similar Documents

Publication Publication Date Title
NO20083405L (no) Nye glycolipidadjuvantsammensetninger
CL2011003113A1 (es) Composicion adyuvante acuosa que comprende un agonista de tlr-4 y una saponina y un agente de isotonicidad no ionico; proceso para la preparacion de una composicion inmunogenica.
MX2018004675A (es) Composicion limpiadora y desinfectante.
WO2011031946A3 (en) Compositions and methods for controlling the stability of ethersulfate surfactants at elevated temperatures
CL2008001383A1 (es) Composición lactea o de sustituto lacteo aireada y liofilizada que comprende un ingrediente lacteo o substituto lacteo, un emulsificante, un mejorador de la viscosidad; y metodo para preparar dicha composicion.
EP2808378A3 (en) Aqueous acidic hard surface cleaning and disinfecting compositions
AR063370A1 (es) Composiciones herbicidas
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
UY32557A (es) Composición endulzante que comprende una forma de rebaudiosida a de alta solubilidad y método para su producción
CL2008002169A1 (es) Metodo para preparar un compuesto derivado de tetrahidro-2h-piran-3,4,5-triol-2,6-disustituido, inhibidor del contransportador de sodio y glucosa 2; compuestos intermediarios; y metodo de preparacion de los compuestos intermediarios.
DOP2010000001A (es) Formulaciones de anticuerpos
BR112014005190A2 (pt) composições em microcápsula compreendendo gelificantes de di-amido ajustáveis por ph
CR8879A (es) Bifeniltiazolcarboxamidas
WO2010108756A3 (de) Wässrige haar- und hautreinigungszusammensetzungen
CL2011001306A1 (es) Composicion antimicrobiana que comprende una sal de plata soluble, una alcanolamida, y/o aminoalcohol, un ph 6 o superior; composicion limpiadora que comprende un surfactante, una sal de plata soluble, una alcanolamida, y/o aminoalcohol.
DOP2011000025A (es) Metodos para entregar una frangancia
MA30711B1 (fr) Sels d'ethers benzimidazolyle pyridyle et formulations associees
UA90569C2 (ru) Композиция гликолипидного адьюванта (варианты) и способ ее получения
NO20073167L (no) Skjaerbeskyttende midler for isolering ved mikrofiltrering
AR075299A1 (es) Formulacion con tendencias de formacion reducida de geles y metodo para reducir la tendencia de formacion de geles
GT200600010A (es) Procedimientos para la preparacion de alcoholes aminoetoxibencilicos
BR112013028607A2 (pt) composições sólidas contendo éter glicólico e água
BRPI0711425A8 (pt) composições compreendendo tensoativos polimerizados de baixo dp e métodos de uso destas
BRPI0516335A (pt) composição de limpeza lìquida/gel e processo para a preparação de uma composição de limpeza lìquida/gel
BRPI0507814A (pt) composição de tratamento capilar, uso de uma composição e método condicionante capilar

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS P LLC, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS SERVICES LLC, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS SERVICES LLC, US